Amdocs Ltd: (NYSE: DOX)

$36.36

-0.07 (-0.19%)

Volume 605,023

May 21 04:02 PM ET

Zacks Rank: 3-Hold

 
 
#3
 
 

Full Company Report

Get Full Company Report for:

Amdocs is a leading provider of customer care, billing and order management systems for communications and Internet services. Amdocs has an unparalleled success record in project delivery of its mission-critical products. With human resources of over 5,900 information systems professionals, Amdocs has an installed base of successful projects with more than 75 service providers throughout the world. In April 2000, Amdocs completed the acquisition of Solect Technology Group Inc., a leading provider of customer care and billing systems for IP providers.

General Information

AMDOCS LTD
SUITE 5 TOWER HILL HOUSE LE BORDAGE ST PETER PORT
ISLAND OF GUERNSEY, X0 GY1 3QT
Phone: 011-44-1481-728444
Fax: 44 31 4212 7500
Web: http://www.amdocs.com
Email: dox_info@amdocs.com

Industry IT SERVICES
Sector Computer and Technology
Fiscal Year End September
Last Reported Quarter 03/31/2013
Next EPS Date 08/07/2013

Price and Volume Information

Zacks Rank
Yesterday's Close 36.43
52 Week High 36.73
52 Week Low 28.16
Beta 1.02
20 Day Moving Average 731,227.63
Target Price Consensus 38.29

% Price Change

4 Week 6.09
12 Week 2.27
YTD 6.77

Share Information

Shares Outstanding (millions) 161.78
Market Capitalization (millions) 5,893.50
Short Ratio 1.11
Last Split Date NA

DOX

% Price Change Relative to S&P 500

4 Week -0.52
12 Week -8.68
YTD -8.68

Dividend Information

Dividend Yield 1.43%
Annual Dividend $0.52
Payout Ratio 0.20
Change in Payout Ratio 0.17
Last Dividend Payout / Amount 03/26/2013 / $0.13

EPS Information

Current Quarter EPS Consensus Estimate 0.67
Current Year EPS Consensus Estimate 2.70
Estimated Long-Term EPS Growth Rate 8.30
Next EPS Report Date 08/07/2013

Consensus Recommendations

Current (1=Strong Buy, 5=Strong Sell) 2.40
30 Days Ago 2.45
60 Days Ago 2.45
90 Days Ago 2.25

Fundamental Ratios

P/E

Current FY Estimate 13.48
Trailing 12 Months 13.80
PEG Ratio 1.63

Price Ratios

Price/Book 1.87
Price/Cash Flow 10.43
Price / Sales 1.79

Current Ratio

03-31-13 2.48
12-31-12 2.28
09-30-12 1.92

Net Margin

03-31-13 12.18
12-31-12 12.18
09-30-12 12.05

Inventory Turnover

03-31-13 NA
12-31-12 NA
09-30-12 NA

EPS Growth

vs. Previous Year 7.94%
vs. Previous Quarter 4.62%
   

ROE

03-31-13 14.16
12-31-12 14.12
09-30-12 14.06

Quick Ratio

03-31-13 2.48
12-31-12 2.28
09-30-12 1.92

Pre-Tax Margin

03-31-13 13.82
12-31-12 13.73
09-30-12 13.60

Debt-to-Equity

03-31-13 0.00
12-31-12 0.00
09-30-12 0.00

Sales Growth

vs. Previous Year 2.97%
vs. Previous Quarter 0.80%
   

ROA

03-31-13 9.63
12-31-12 9.56
09-30-12 9.49

Operating Margin

03-31-13 13.22
12-31-12 13.16
09-30-12 13.07

Book Value

03-31-13 19.47
12-31-12 19.04
09-30-12 18.38

Debt to Capital

03-31-13 0.00
12-31-12 0.00
09-30-12 0.00

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.